Approval · Notice of Compliance 17376 · 2015
VALACYCLOVIR: Notice of Compliance 17376
Issued October 14, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17376
- Date
- October 14, 2015
- Company
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Licensing agreement between two companies
- Canadian reference product
- VALTREX (Glaxosmithkline Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VALACYCLOVIR | 02442000 | Marketed |
| VALACYCLOVIR | 02442019 | Cancelled Post Market |
Medicinal ingredients
- VALACYCLOVIR HYDROCHLORIDE 500 MG per CAP
- VALACYCLOVIR HYDROCHLORIDE 1,000 MG per CAP